期刊文献+

高危型HPV DNA负荷量在预测CINⅠ转归可能性中的价值 被引量:4

The Value of Hing-risk Human Papilloma Virus Viral Load in Predicting Outcome of CIN I
下载PDF
导出
摘要 目的:探讨高危型人乳头瘤病毒(HR-HPV)DNA负荷量在宫颈上皮内瘤变(CIN)Ⅰ级的转归预测中的价值。方法分析2009年~2012年就诊于济南市第五人民医院的CINⅠ患者156例,分为观察组和微波治疗组。于6个月、12个月、18个月、24个月复查液基细胞学检查(TCT),对HR-HPV阳性患者复查HR-HPV DNA负荷量,对细胞学检查中出现ASCUS及以上改变者或HR-HPV DNA持续2年仍阳性者在电子阴道镜下行宫颈活检,比较随访2年后两组HR-HPV DNA负荷量的变化,不同HR-HPV DNA负荷量CINⅠ转归情况,CINⅠ不同转归组中HR-HPV DNA负荷量变化。结果①随访2年后微波治疗组HR-HPV DNA负荷量明显低于观察组(P<0.01)。微波治疗组治疗后2年HR-HPV DNA负荷量较治疗前明显下降(P<0.01)。②高负荷量组中观察组病变持续存在或进展为CINⅡ及以上病变比率高于微波治疗组(P<0.05)。观察组中高度负荷量组随访2年后发生病变持续存在或进展为CINⅡ及以上病变比率高于中度负荷量组,差异有统计学意义(P<0.05)。③HR-HPV DNA负荷量与病理学改变程度呈正相关,随着病变级别的升高,HR-HPV DNA负荷量增高(P<0.05)。结论 CINⅠ患者的随访中可依据HR-HPV DNA负荷量对CINⅠ转归进行评估,对于不同HR-HPV DNA负荷量采取不同的治疗方案。 Objective To investigate the value of high-risk human papillomavirus DNA load in predicting the outcome of CINⅠ. Methods From 2009 to 2012,156 cases were diagnosed as CINⅠin fifth people's hospital of Jinan city .They were divided into observation group and microwave treatment groups .After 6 months,12 months,18 months and 24 months,they were reviewed liquid-based cytology.HR-HPV-positive cases were reviewed HR-HPV DNA load.The cases who appeared to ASCUS or above ASCUS were biopsied under colposcopy . The cases who remained HR-HPV DNA positive for two years were biopsied under colposcopy .The changing of HR-HPV DNA load after 2 years,the outcome of CINⅠin different HR-HPV DNA load groups and the changing of HR-HPV DNA load in different CINⅠoutcome groups were compared .Results ①After 2 years the HR-HPV DNA load of microwave group was significantly lower than that in observation group ( P〈0.01).HR-HPV DNA load decreased significantly after microwave treatment than before treatment (P〈0.01).②In high HR-HPV DNA load group,the incidence rate of CINⅡor worse in observation group were higher than in microwave treatment groups after 2 years(P〈0. 05).In observation group,the incidence rate of CINⅡor worse in high load group was higher than in middle load group (P〈0.05).③HR-HPV DNA load was positively correlated with the pathological degree .According with the levels of cervical lesions ,HR-HPV DNA load in-creased(P〈0.05).Conclusion In following-up of cases with CINⅠ,we can evaluate outcomes of CINⅠaccording to HR-HPV DNA load. Cases with different HR-HPV DNA load should adopt different treatment .
出处 《潍坊医学院学报》 2015年第4期300-302,共3页 Acta Academiae Medicinae Weifang
关键词 高危型人乳头瘤病毒 宫颈上皮内瘤变 病毒负荷量 转归 Hing-risk human papilloma virus Cervical intraepithelial neoplasia Viral load Outcome
  • 相关文献

参考文献8

  • 1李小华,王俊然,冬国友,刘志英.高危型人乳头瘤样病毒DNA检测在宫颈癌早期筛查中的作用[J].重庆医学,2013,42(8):939-940. 被引量:43
  • 2梅丽,李丽,刘婷婷.高危型HPV病毒负荷量指导CINⅠ的治疗分析[J].中国计划生育和妇产科,2013,5(3):36-39. 被引量:2
  • 3Ostor AG. Natural history of cervical intraepithelial neoplasia: acritical review [ J 1. lnt J Gyneeol Pathol, 1993,12 ( 2 ) : 186 - 192.
  • 4Massad LS, Einstein MH, Huh WK, et al. 2012 updated consensus guidelines for the management of abnormal cervical caneer screening tests and cancer precursors [ J 1. Obstet Gynecol, 2013,121 (4) : 829 846.
  • 5张文璎,薛月珍,韩玲,罗曼.高危型人乳头瘤状病毒负荷量与宫颈病变严重程度的关系[J].上海交通大学学报(医学版),2007,27(11):1354-1357. 被引量:14
  • 6Pierry D, Weiss G, Lack B, et al. Intracellular human papillomavirus E6,E7 mRNA quantification predicts CIN2 + in cervical biopsies bet- ter than Papanicolaou screening for women regardless of age [ J ]. Arch Pathol Lab Med ,2012,136 ( 8 ) :956 - 960.
  • 7Cox JT, Castle PE, Behrens CM, et al. Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV16/18 :results from the ATHENA HPV study [ J 1. Am J Obstct Gynecol,2013,208 ( 3 ) : 184.
  • 8AI-Awadhi R, Cbehadeb W, AI-Jassar W, et al. Viral load of human papillomavirus in women with normal and abnormal cervical cytology in Kuwait [ J]. J Infect Dev Ctries ,2013,7 (2) : 130 - 136.

二级参考文献32

  • 1钱德英,岑坚敏,王丁,曾仁海,林爱华,舒焰红,洪淡华,黄志宏.高危型人乳头状瘤病毒DNA检测与细胞学联合检查对子宫颈癌前病变筛查的研究[J].中华妇产科杂志,2006,41(1):34-37. 被引量:168
  • 2Munoz N. Human papillomavirus and cancer: the epidemiological evidence[J]. JClin Virol, 2000, 19(1 -2):1-5.
  • 3Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population[ J]. Int J Cancer, 2002, 97(1) :72 -81.
  • 4Wu Y, Chen Y, Li L, et al. Associations of high-risk HPV types and viral load with cervical cancer in China [ J ]. J Clin Virol, 2006, 35(3) :264 -269.
  • 5Carvalho MO, Carestiato FN, Perdigao PH, et al. Human papillomavirus infection in Rio de Janeiro, Brazil: a retrospective study [J]. Braz J Infect Dis, 2005, 9(5) :398 -404.
  • 6Bosch FX. Epidemiology of human papillomavirus infections : new options for cervical cancer prevention [ J ]. Salud Publica Mex, 2003, 45( Suppl 3) :S326 - S339.
  • 7Schiffman MH. Epidemiology of cervical human papillomavirus infections[ J]. Curr Top Microbiol Immunol, 1994, 186:55 -81.
  • 8Bory JP, Cucherousset J, Lorenzato M, et al. Recurrent human papillomavirus infection detected with the hybrid capture Ⅱ assay selects women with normal cervical smears at risk for developing high grade cervical lesions: a longitudinal study of 3,091 women[ J]. Int J Cancer, 2002, 102(5) :519 -525.
  • 9Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study [ J ]. Lancet,1999, 354(9172) :20 -25.
  • 10Zielinski GD, Snijders PJ, Rozendaal L, et al. HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears [ J ]. Br J Cancer,2001,85 ( 3 ) :398 - 404.

共引文献56

同被引文献34

  • 1Rashid S, Khaund A, Murray LS, et al. The effects of uterine ar- tery embolisati-on and surgical treatment on ovarian function in women with uterine fibroids [ J ], B JOG, 2010,117 ( 8 ) :985 -989.
  • 2Katki HA, Kinney WK, Fetterman B, et al. Cervical cancer risk for women un-dergoing concurrent testing for human papillomavirus and cervical cytology:a p-opulation-based study in routine clinical practice [ J ]. Lancet Oneol, 2011,12 ( 7 ) :663-672.
  • 3Andersson S, Sowjanya P, Wangsa D, et al. Detection of genomic aplificationof the haman telomerase gene TERC, a potential mark- er for triage of women with HPV-positive, abnormal Pap smears [J]. Am J Pathol, 2009,175($) :1531-1S47.
  • 4Nafisawa-Saito M, Handa K, Yugawa T. HPV16 E6-mediated sta- bilization of ErbB2 in neoplastic transformation of human cervical keratinoeytes[ J]. Oncogene, 2007,26 ( 21 ) :2988-2996.
  • 5Kuglik P, Kasikova K, Smetana J, et al. Molecular cytogenetic an- alyses of hT-ERC(3q26) and MYC(8q24) genes amplifications in correlation with ongeneni human papillomavirus infection in Czech patients with cervical intraepithelial n-eoplasia and cervical carci- nomas[J]. Neoplasma, 2015,62(1) :130-139.
  • 6Li T, Tang L, Bian D, et al. Detection of hTERC and c-myc genes in cervical epithelial exfoliated cells for cervical cancer screening [J]. Int J Mol Med, 2014,33(5) :1289-1297.
  • 7江维,李隆玉.宫颈上皮内瘤变Ⅰ级的自然转归与随访观察[J].实用癌症杂志,2009,24(2):188-190. 被引量:11
  • 8荣晅,乌兰娜,高积勇,周艳秋,王纯,吴瑞芳.宫颈上皮内瘤变Ⅰ级的自然转归研究[J].现代妇产科进展,2012,21(5):365-368. 被引量:11
  • 9刘聃,魏力.hTERC基因、C-MYC基因表达在宫颈病变中的意义[J].现代诊断与治疗,2012,23(4):300-301. 被引量:1
  • 10张蕾,赵计端.液基薄层细胞学结合TBS系统对宫颈癌筛查的临床意义[J].现代预防医学,2013,40(1):35-37. 被引量:12

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部